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Abstract
Background The application of mechanical pressure by
compression devices has gained popularity in the treat-
ment of keloid scars. In this present study, we analyze
the long-term efficacy of our custom-molded pressure
clip for ear keloids. Our secondary objective is to iden-
tify risk factors for the failure of the treatment in the
group of the recurrence.
Methods The patient group consisted of 9 men and 19 women
with amean age of 27 years and amean follow-up of 8.5 years.
For evaluation of the scars, scoring ratings, Patient and
Observer Scar Assessment Scale (POSAS), and SF8-
questionnaire have been used.
Results Follow-up observations showed that 71 % were treat-
ed successfully. There were significant differences in the
Fitzpatrick scale, cause of the ear keloids, overall opinion,
and openness for re-treatment between the recurrence and
nonrecurrence group. Furthermore, treatment with our
custom-molded pressure ear clip resulted in a statistically
significant improvement of all the item scores of the POSAS
in both the patient and observer scales. Severe complications
such as infections or necrosis were not noted.
Conclusions In this study, we show that the results of
adjuvant pressure therapy with our custom-molded ear
clips are comparable with the recurrence rates of other
studies recently published. The strength of this study is
the long follow-up.
Level of Evidence: Level III, therapeutic study
Keywords Ear keloids . Pressure therapy . Pressure clips .
POSAS . Preliminary study . Keloid . Therapy
Introduction
Keloids are a disease well known to mankind for a long time.
The first description of abnormal scar formation in the form of
keloids was recorded in the Smith papyrus regarding surgical
techniques in Egypt around 1,700 B.C. Even almost
4,000 years later, management of keloids remains a challenge
for both the clinician and the patient. Keloids are defined as
benign fibrous skin tumors which grow at the site of a skin
wound but beyond the margins of the wound. The aspect is
mostly darker in color in comparison to normal skin. It is
known that keloids are the result of a dysfunctional scarring
process that leads to an overabundance of collagen deposits
[1], which results in growing of this scar causing discomfort
and disfigurement.
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The exact incidence of keloids remains to be unknown, but
several studies show an incidence of approximately 2–2.5 %
[2, 3] and at 4.5 to 16% in the black and Hispanic populations
in several large series [4]. Different types of injury can be a
cause of keloids: e.g., ear piercing, burns, trauma, surgery,
tattooing, vaccination, or even insect bites. Since skin and
wound tension is considered a critical factor in the formation
of keloids, the most susceptible sites are the central chest, the
back, the shoulders, and, interestingly, also the ear lobes [5].
Numerous therapeutic modalities have been used to treat
auricular keloids including intralesional corticosteroid injec-
tion [6], pressure therapy [7, 8], cryotherapy [9], radiotherapy
[3, 10, 11], laser therapy [12, 13], surgical excision, or a
combination [6, 14, 15]. The variety of treatments for keloids
suggests that none of these widely used therapies is satisfac-
tory [7, 16–18]. One of the major problems encountered
during the therapy of earlobe keloids is the problematic and
even sometimes impossible way of applying pressure to the
keloid. This is mostly due to the peculiar shape of the ear that
makes it difficult to give compression. This results in higher
rates of therapy failure and recurrence of keloids. Nowadays,
new ear pressure clips have been developed [16–19] with
different results in terms of effectiveness, comfort, and cos-
metic appearance.
In recent years, there has been the development of adjuvant
pressure therapy by using a custom-mademethyl methacrylate
stent as published by Kadouch et al. [16]. This study uses a
different device which shares the same principle as the device
published by Kadouch et al. but includes more patients and
has a longer follow-up.
Most of the pressure devices lack control of the
amount of pressure applied to the keloid; however,
our device has been optimized in order to allow the
pressure to be adjusted. Furthermore, using our device
makes it possible to also treat retro-auricular keloids
(Figs. 1 and 2).
In this present study, we analyzed the long-term efficacy of
this pressure device for ear keloids. Our secondary objective
was to identify risk factors explaining for the failure of the
treatment in the recurrence group.
Material and methods
Between 2003 and 2006, we treated 28 consecutive patients
using a combination therapy of excision and our custom-
molded pressure clip. Two weeks after excision of the keloid,
a plaster cast of the ear was made. Then, by using the cast as a
mold, a silicon liner was fabricatedmatching the surface of the
ear. When fitted over the ear, the silicon liner was covered on
both sides of the ears with two custom-made artificial auricles:
one pre- and one retro-auricular. The fitting of which was
enabled by the thermoplastic properties of the fabric as well
as by a one-way click–and–fit system. In addition, these
auricles could be pressure adjusted by a U-shaped screw–
and–pin system.
The custom-molded clips ensure a hydrated environ-
ment due to the choice of a silicon fabric. In addition,
their effectiveness relies on the adjustability of the pres-
sure on exactly those points where keloid recurrence is
anticipated. Hence, the pressure can be variably adjusted
during daytime ensuring a maximum capacity of the
device to reduce keloid recurrence. The pressure is
adjusted based on the patient’s discomfort. However,
we anticipated that most of the discomfort is related
initially to the patient’s awareness of the clip upon
wearing. Therefore, we designed a habituation scheme:
On the first day, the pressure is maximized to enable a
wearing time of 1 h. The next day, it is adjusted so that
it can be worn for 2 h, and then for 3 h the following
day and so on until it is worn for 12 h consecutive with
a minimum amount of discomfort. After 2 weeks, the
pressure is augmented again until the pressure area in
and around the scar blanches, but without discomfort
and pain. This is the onset of therapy. Subsequently,
any evidence of keloid recurrence is closely monitored
in follow-up. If present (i.e., scar thickness increases),
Fig. 1 Our custom-molded pressure clip. Note the different pressure
mechanisms
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this means that the scar area may not be targeted
properly and pressure adjustments are made accordingly
either by relocating the pressure or by increasing it.
During therapy, an interdisciplinary team assessed the
keloid every 3 months in our outpatient clinic. The
therapy is continued for an average of 12–15 months
(12–16 h/day). Normally, the scar is then free of edema,
colorless, and pliant. Post-therapy follow-up is pursued
each year for 3 years. Within therapy, discontinuation
standards comprise the following: (1) keloid recurrence
in spite of corticoid injections, (2) more than two times
therapy-related pressure ulcer occurrence, and (3) no-
show of patients in follow-up. Before participation in
the present study, informed consent was obtained from
all patients and the medical record was retrieved from
the archive. Follow-up was performed at the outpatient
clinic or by telephone interview.
Statistical analysis
Continuous variables are presented as means with standard
deviations or as medians with interquartile ranges. Categorical
variables are presented as percentages. Continuous variables
Fig. 2 Left side: keloid in the
upper pole/helix of the ear and
retro-auricular area. Right side:
appearance after therapy with our
custom-molded pressure ear clip
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were compared between groups using unpaired Student’s t tests
or Mann–Whitney U tests as appropriate. Categorical variables
were compared between groups using chi-square tests or Fisher’s
exact tests as appropriate. Changes in continuous variables be-
fore and after treatment were compared using paired Student’s t
tests. A P value of 0.05 was considered statistically significant.
Statistical analysis was performed using SPSS version 20.0.
Results
The patient group consisted of 9 men and 19 women with a
mean age of 27 years (18–66 years) and a mean follow-up of
8.5 years (6.9–12.3 years). All patients were classified
Table 1 Patient characteristics
and risk factors between the re-
currence and nonrecurrence
groups and P values. (The figures
in brackets mean the standard de-
viation or the first and third
quartile)
*p≤0.05
Recurrence,
N=8 (29 %)
Nonrecurrence,
N=20 (71 %)
P
Gender (male) 50 % 25 % 0.37
Age (years) 25 (8) 27 (11) 0.50
Positive family history (%) 0 15 0.54
BMI (kg/m2) 22 (5) 24 (4) 0.22
Fitzpatrick scale III (III–IV) III (II–III) 0.05*
Anatomical location (%) 0.32
Upper pole 25 20
Lobule 25 55
Retro-auricular 50 25
Cause (%) 0.04*
Ear piercing 25 60
Otoplasty 75 25
Trauma 0 15
Previous treatment (%) 0.76
None 63 65
Surgical excision 13 10
Injections 25 15
Brachytherapy 0 10
Patient compliance (%) 0.60
<8 h a day 13 15
8–12 h 50 30
>12 h 38 55
Therapy duration (months) 18 (10) 15 (6) 0.44
Comfort 5.00 6.75 0.11
Appearance 4.13 5.25 0.23
Overall opinion 4.63 8.05 0.02*
Open for re-treatment (yes) 37.5 % 100 % 0.01*
Enhanced quality of life (yes) 25 % 60 % 0.21
Table 2 Identifying risk factors between the recurrence and nonrecurrence
groups and P values
Patient scale Before therapy Last follow-up P value
Pain 4.25 1.11 <0.001*
Itching 5.04 2.00 <0.001*
Color 5.79 1.54 <0.001*
Stiffness 8.39 3.25 <0.001*
Thickness 8.54 3.00 <0.001*
Irregularity 8.00 2.54 <0.001*
Overall opinion 9.14 3.07 <0.001*
*p≤0.05
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according to the Fitzpatrick scale (types I–VI). Additional
questions in terms of comfort, appearance, and overall opinion
of the ear clip have been scored from 1 (worst) to 10 (best) and
are documented in Table 1. Furthermore, by using the
SF-8 questionnaire, we asked the patients if they would
undergo the same treatment again and if the treatment
had affected their quality of life [20]. Follow-up obser-
vations showed that 20 patients (71 %) were treated
successfully and 8 patients (29 %) developed recur-
rence. For evaluation of possible differences between
the recurrent and nonrecurrent group, variables defining
the patient population were evaluated and risk factors
for failure of treatment were identified. There were
significant differences in the Fitzpatrick scale, cause of
the ear keloids, overall opinion, and openness for re-
treatment between the recurrence and nonrecurrence
group. No significant differences were found for the
further parameters. In the nonrecurrence group, patients
are more compliant to therapy than the nonrecurrence
group (55 % >12 h of wearing) compared to the recur-
rence group (38 % >12 h of wearing). In the
nonrecurrence group, patients were generally satisfied
(8.05; overall opinion), but disliked the appearance of
the ear clip (5.25; appearance). The comfort of the ear
clip was acceptable, but should be improved (6.75;
comfort). In the recurrence group, patients were gener-
ally discontent (4.63; overall opinion). However, com-
fort and appearance were judged similarly as in the
nonrecurrence group. Of note, 37.5 % of the patients
in the recurrence group repeat the treatment and 25 %
of these patients experienced an enhanced quality of
life.
In this study, the Patient and Observer Scar
Assessment Scale (POSAS) was used to evaluate the
scars (Table 2, 3, and 4). The POSAS is a comprehen-
sive scale designed for the evaluation of all types of
scars by professionals as well as patients [21, 22].
Treatment with our custom-molded pressure ear clip
resulted in a statistically significant improvement of all
Table 3 Comparison of the POSAS observer scale before therapy and the
last follow up and P values
Observer scale Before therapy Last follow-up P value
Vascularity 3.82 2.18 <0.001*
Pigmentation 3.04 1.82 0.01*
Thickness 6.89 3.32 <0.001*
Relief 5.75 3.00 <0.001*
Pliability 6.93 3.18 <0.001*
Surface area 7.07 3.25 <0.001*
Overall opinion 7.00 3.29 <0.001*
*p≤0.05
Table 4 Total scores of the POSAS before therapy, on last follow-up, and
relative reduction in POSAS as well as P values
Recurrence Nonrecurrence P value
POSAS score before treatment 81.50 92.90 0.08
POSAS score last follow-up 56.13 28.70 0.01*
POSAS score reduction 25.38 64.20 0.01*
*p≤0.05
Table 5 Side effects from using our custom-molded pressure ear clip
Side effect Number (%)
None 6 (21 %)
Discomfort 17 (61 %)
Pruritis 4 (14 %)
Skin irritation 7 (25 %)
Transient pressure ulcer 5 (18 %)
Scarring with poor cosmetic results 0 (0 %)
Infection 0 (0 %)
Fig. 3 Pressure ulcer as a complication
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the item scores of the POSAS in both the patient and
observer scales. The total score of the POSAS before
treatment showed no statistically significant differences
between the recurrence and nonrecurrence group. Lastly,
the complaints or side effects of the ear clips were
evaluated and documented in Table 5. Sixty-one percent
of the patients were found to have discomfort during
the application of the pressure clip. A relatively small
number of patients complained about pruritus (14 %),
skin irritation (25 %), and transient pressure ulcer with
no permanent damage or scarring to the ear (18 %,
Fig. 3). Severe complications such as infections or skin
necrosis leading to scarring and poor cosmetic results
were not noted.
Discussion
Since the use of pressure therapy by Ambroise Paré for the first
time in 1678 [23], the application of mechanical pressure by
compression devices has gained popularity in the treatment of
keloid scars. Surgery alone leads to recurrence rates ranging
from 45 to 100 % [24]. Combined with compression devices,
recurrence rates drop to 10–20% [16, 18]. Nowadays, pressure
earrings are widely used as an adjunct to surgery in the treat-
ment of auricular keloids. Chalian et al. [7] postulated that the
ideal characteristics of pressure earrings should be “noninflam-
mable, strong enough to resist distortion, light in weight,
comfortable to wear, and easy for the patient to apply and
remove. It must provide uniform adjustable compression and it
must not interfere with normal hearing. It should also be
inexpensive, easy to fabricate, esthetically acceptable, and
easy to clean for proper hygiene.”
Various compression devices have been described in
literature: spring pressure earrings [8], silicone-sheeted
earrings [6], custom-made silicone ear mold [19], mag-
netic disks [18, 25], acrylic resin devices [15, 26], U
loop devices [17], Zimmer splintage [27], aluminum
finger splints [28], and methyl methacrylate stents [16,
29]. Our pressure device consists of a custom-molded
silicone with up to three separate adjustable pressure
mechanisms.
In a similar study to ours using a methyl methacrylate stent,
Kadouch et al. had an overall success rate of 83%with a mean
follow-up of 23 months. In our study, we observed a 71 %
success rate with a mean follow-up of 8.5 years. It might thus
appear that our method is less effective than theirs, but as we
have seen in this study, keloid recurrence can occur as late as
3 years after primary therapy. The success rate of Kadouch
et al. may thus in fact be lower than presented. We advise a
long follow-up to evaluate the effectiveness of therapy
methods in scar treatment.
While a positive family history for keloids has been asso-
ciated with keloid recurrence, we were not able to confirm this
[16]. On the other hand, we could confirm that darker-skinned
patients were more prone to recurrence than lighter-skinned
patients. This appears logical since people with a higher
Fitzpatrick skin type also have a higher incidence of keloids
[4]. We also have found that keloids resulting from otoplasty
had a higher recurrence rate than other causes. This is proba-
bly related to a more extensive damage to the soft tissue of the
ear in comparison to smaller injuries caused by ear piercings
for example. Another possible explanation is a more
prolonged immunologic reaction on dissolvable suture mate-
rial used in otoplasty. As for the therapy compliance rates,
there is a trend towards a correlation between compliance and
nonrecurrence, although this does not reach statistical signif-
icance. This further highlights the link between therapy effec-
tiveness and outcome, and if true, doctors should encourage
patients to wear the device as long as needed.
Using the POSAS score, we observed a statistically signif-
icant improvement in all the items of the POSAS between
before therapy and the last follow-up. This confirms the
efficacy of our custom-molded device. Since the total
POSAS score before therapy showed no statistically signifi-
cant difference between the recurrence and nonrecurrence
groups, we can conclude that recurrence does not depend on
clinical presentation upfront. Therefore, someone with a high
or low POSAS does not predict recurrence. In other words, it
does not matter how bad the POSAS score is preoperatively;
the chances for success are equal.
In addition, patients rated the comfort, appearance, and
overall opinion as acceptable, but people with recurrence
had less comfort. A possible explanation could be that the
adjustments had not been made appropriately, and therefore,
the containment of the wound was suboptimal, resulting in a
higher chance of recurrence. Put differently, the compression
in these patients was maybe not centered on the point of
interest.
Sixty-one percent of patients first complained about
discomfort which seems very high; however, because
our device can adjust the pressure, we can relieve this,
in contrast to most pressure ear clips lacking the ability
of applying accurate and independent pressure on the
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ear keloids. Another benefit is the prevention of severe
complications such as tissue necrosis with permanent
damage, because of the application of a homogenous
pressure. Therefore, it is our opinion that our custom-
molded ear clip, in terms of effective applied pressure
on the keloids, is superior to conventional ear clips.
The main drawback is the size of our custom-molded
ear clip and the relatively unattractive aesthetic appear-
ance of this device. In comparison to Park’s device
using magnets [18], our device is more obvious and
unattractive, but as previously prescribed, Park’s device
lacks the ability to adjust the pressure. However, most
of the other existing devices such as the U loop pres-
sure clip [17] and the methyl methacrylate stent [16]
are, in our opinion, a bit more or equally cosmetically
appealing. However, most of the patients were satisfied
with this therapy in general. To support this finding, we
have found that 37.5 % of patients with recurrence
would choose the treatment again. This means that even
if we consider recurrence as a failure, actually for the
patient this is not the case. These patients are satisfied
or at least free from the keloid for several years and if
they would have to undergo the treatment again, they
would.
In summary, in this study, we show that the advan-
tages of our custom-molded pressure ear clip are the
retro-auricular treatment option, adjustable pressure, and
minimal severe complication rate. The main disadvan-
tage is the unattractive appearance. The results of adju-
vant pressure therapy with our ear clips are comparable
with the recurrence rates of other studies recently pub-
lished [16, 18]. The strength of this study is the long
follow-up. Since the number of patients is moderate, a
larger patient group is needed to more accurately inves-
tigate and determine the efficacy of adjuvant pressure
therapy for treatment of ear keloids.
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